(Q73614678)

English

Significance of the Thrombolysis in Myocardial Infarction scoring system in assessing infarct-related artery reperfusion and mortality rates after acute myocardial infarction

scientific article published on 01 July 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266784%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

Significance of the Thrombolysis in Myocardial Infarction scoring system in assessing infarct-related artery reperfusion and mortality rates after acute myocardial infarction (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266784%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

Abdallah Al-mohammad

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266784%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

F Fath-Ordoubadi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266784%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Y Huehns

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266784%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K J Beatt

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266784%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

0 references

publication date

1 July 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266784%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266784%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

134

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266784%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266784%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

62-68

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266784%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction trials)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

TIMI frame count: a quantitative method of assessing coronary artery flow

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Residual flow to the infarct zone as a determinant of infarct size after direct angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: A qualitative and quantitative angiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Usefulness of recanalization to luminal diameter of 0.6 millimeter or more with intracoronary streptokinase during acute myocardial infarction in predicting "normal" perfusion status, continued arterial patency and survival at one year

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Misleading meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Time course of left ventricular function and coronary patency after saruplase vs streptokinase in acute myocardial infarction. The PRIMI Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970107-8

7 January 2021

Identifiers

10.1016/S0002-8703(97)70107-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266784%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266784%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73614678&oldid=1742046156"